RYAH) Unearthing groundbreaking discoveries that will reshape the understanding of herbal medicines


News and research before you hear about it on CNBC et al. Claim your 1-week free trial for Street Insider Premium here.

RYAH Group (CSE: RYAH) is a leading herbal medicine data technology company committed to delivering valuable insights and transforming patient care through big data and artificial intelligence. According to a recent article, which contains excerpts from a RYAH blog post, “The company strives to uncover groundbreaking discoveries that will redefine the understanding of herbal medicines.” In the blog post, for example, RYAH provided an overview of the legal UK cannabis market, observing that “market analysts continue to place high hopes in the potential of the UK market. Yet in its current form, there is still a long way to go for the UK system. The blog post highlighted that access to medical cannabis is restrictive in the UK, further signaling that the country is ready for change. “In 2020, Prohibition Partners suggested that the UK market could reach £ 2.31 billion (US $ 3.13 billion) by 2024. Statista offered an updated estimate in 2021, predicting that the market will reach US $ 1.29 billion by 2024. At the current rate, those numbers seem elusive, but the change is coming.

To view the full article, visit https://ibn.fm/fgQcW

About RYAH Group Inc.

RYAH is a connected devices and big data and technology company focused on predictive analytics valuable to the global herbal medicine and nutraceutical industry. Its robust artificial intelligence platform aggregates and correlates patient data compliant with the Health Insurance Portability and Accountability Act (HIPAA), which aims to help physicians and patients personalize herbal treatments for better predict treatment results. Data collection is relevant for clinics, physicians, dispensaries and pharmaceutical companies and licensed processors (“LPs”) to monitor and manage the effects of the formulation on patients and demographics. With a strong intellectual property portfolio, RYAH brings together in-depth and insightful data on the complete patient session and formulation lifecycle. For more information, visit www.RYAHGroup.com.

NOTICE TO INVESTORS: The latest news and updates relating to the RYAH Group are available in the Company’s press room at https://ibn.fm/RYAH

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we’ve got the wire-quality delivery products you’ll need to make sure your next press release grabs the attention of your target audience and doesn’t let go. While our competitors seek to offer you hidden fees and restrictive word limits, InvestorWire is keeping things transparent. We offer UNLIMITED Words on all national outings. While other communications services can provide a basic review of your release, InvestorWire helps you do your best with Improved press release.

At our competitors, the job is done the second your exit goes on the wire. Not with InvestorWire. We include follow-up coverage of every release taking advantage of the ever-growing audience for the 50+ brands who make up the InvestorBrandNetwork.

Make the most of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please review the full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever posted or republished: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, California 90046
310.299.1717 Office
[email protected]

InvestorWire is part of InvestorBrandNetwork.

Source link


Comments are closed.